Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
For full access to this article login to GEN Select now.
Finer Points of Single-Use Bioprocessing
From our January 15 issue: Processing in plastics is maturing, with users focusing on cell/product retention, rapid prototyping, and streamlined operations.
- The confluence of several developments—expression system improvements, greater familiarity among regulators and drug makers, and component availability—has created a near-perfect environment for adopting single-use processing. While the complications that remain have not yet been reduced to “engineering problems,” they are becoming more manageable. The industry has made great ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.